contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


arcamea-launches-its-first-product-the-efemia-bladder-support-october-1st-in-sweden

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Karin Bryder, CEO says: "Women deserve more effective solutions that are motivating to use and easily fit into their everyday lives. To achieve this with Efemia, we have used a holistic approach...

Karin Bryder, CEO says:  "Women deserve more effective solutions that are  motivating  to use and easily fit into their everyday lives. To achieve this with Efemia, we have used a holistic approach in developing the product, , prioritizing reliability, functionality and emotional aspects equally.  We are very excited to be launching Efemia and truly believe it will transform everyday life for women living with stress urinary incontinence." Efemia's design and operating mechanism is based on the same scientific principles and methodology as behind mid-urethral sling surgery, the most common surgical solution to correct SUI. <hl2>Innovative Aspects </hl2><ul><li/></ul>Efemia achieves its intended purpose by providing the same effect as a Mid Urethral Sling, but without the surgery.  <hl2> </hl2><ul><li/></ul>Continence is more dependent on the urethra than the bladder neck. Efemia reduces urine leakage in women with stress urinary incontinence by supporting the mid urethra. This in contrast  to most devices which support the bladder neck.  <hl2> </hl2><ul><li/></ul>Efemia is  designed to ensure the correct positioning every time it is used without aids of medical professionals or applicators. Efemia has been validated in a randomised, controlled multi-center trial  which showed a significant reduction in urine leakage and that the device is safe to use. The women who used Efemia achieved an average reduction in urine leakage  of 77%  and  85% of the  participants found the product easy to use.  97 women participated in the clinical trial which was held across 4 clinics in Sweden in 2017. The study was coordinated by Aino Fianu Jonasson, Senior Consultant at the Karolinska University Hospital in Stockholm. Efemia Bladder Support is a certified CE Class IIb Medical Device Retail Prices   Efemia single pack:  SEK 1290,-   Efemia Trial pack(all 3 sizes): SEK 1590,- Efemia will be available for online purchase in Sweden from October 1st 2018

Arcamea launches its first product, the Efemia Bladder Support, October 1st in Sweden.